Advancing Safe, Efficacious, & Long-Lasting Delivery to the Eye

2026 Full Event Guide

This Event Has Now Run

Thank you to our speakers, sponsors, and delegates who joined us in San Francisco! If you are interested in the 2027 event, please get in touch at: info@hansonwade.com

Innovating Patient-Centric, Longer-Lasting Delivery to Specific Ocular Targets to Strengthen Adherence to Transformative Ophthalmic Therapies with Enhanced Durability & Formulation

As the global burden of retinal and ocular diseases continues to rise, the race to develop safer, longer-lasting, and less invasive treatments is accelerating, and at the heart of that challenge lies drug delivery. The 4th Ophthalmic Drug Delivery Summit arrived at a pivotal moment, brought together 80+ leading experts from pharma and biotech to tackle the toughest delivery hurdles limiting the impact of cutting-edge therapeutics.

With industry momentum building around sustained-release technologies, suprachoroidal administration, and innovative device-drug combinations, this summit was your gateway to the breakthroughs redefining ocular treatment. From translating long-acting formulations into clinical success to navigating regulatory complexities early, this was the only event dedicated to transforming how and where ophthalmic therapies work - making it a must-attend for anyone shaping the future of eye care.

Download the 2026 Agenda

I truly enjoyed the intimate nature of the conference. It allowed for great networking with people at the top of the field as well as those just entering it.

Chemistry, Manufacturing & Controls Program Management Manager, Regeneron Pharmaceuticals